The Centenary Institute has collaborated with fellow medical research institute, the Hudson Institute in Victoria, to develop a novel model system for accurately monitoring tumour stage and immune cells involvement.
Head of Centenary’s Liver Enzymes in Metabolism and Inflammation Program, Professor Mark Gorrell, was involved in the research project.
Ovarian cancer develops slowly and the immune system is crucial in controlling the tumour. In this particular study, the researchers modified ovarian cancer cells so they glowed in a way that can be seen in live laboratory mice models – enabling counts of tumour cells and immune cell subsets when each tumour is removed.
This system has allowed the researchers to learn new information on tumour growth, as well as discover which immune cells are in the tumour.
The researchers plan to apply the model to other cancers, including liver cancer.
Read the full study online in scientific journal Cancers.
Learn more about how Professor Gorrell’s team at Centenary is working to help develop a new liver disease test.
Inflammation is all good. It is an essential repair process that heals the body, defends it from infection.
However it is also a very powerful process, which when left unchecked causes many diseases directly (like arthritis) but also indirectly (like cancer and vascular disaeses).
A new aspect of inflammation is coming to light, its connection with chronic metabolic diseases, like obesity and diabetes.
In fact its has been given a new name ‘Metaflammation’.
One of the reasons this link is really important is that we are able to control with small molecule or biological therapeuti s some aspects of inflammation and thus this approach might become really useful in treating some diseases that were thought to be diet or environment influenced..and are looking to become a devastating problem in the future.